Title:
HYBRID IMPLANT
Document Type and Number:
WIPO Patent Application WO/2021/215728
Kind Code:
A1
Abstract:
The present invention relates to an implant and a technology of a hybrid implant which combines the advantages of both a one-piece implant and a two-piece implant, wherein the hybrid implant comprises: a fixture including a body having a screw, and a protrusion part which protrudes high from the upper end surface of the body and includes a coupling surface inclined at a predetermined angle; and a cap-type abutment having a concave coupling groove which is formed on the lower end surface thereof and has an inclined angle corresponding to the coupling surface, wherein the abutment is coupled to the fixture in a cold-welding manner by fitting and pressing the protrusion part into the coupling groove.
Inventors:
PAIK SEUNG KWAN (KR)
JEONG GAB MOON (KR)
HAN EUI JIN (KR)
PARK YOUNG HWAN (KR)
JEONG GAB MOON (KR)
HAN EUI JIN (KR)
PARK YOUNG HWAN (KR)
Application Number:
PCT/KR2021/004601
Publication Date:
October 28, 2021
Filing Date:
April 13, 2021
Export Citation:
Assignee:
SHINSAEGI MEDI TECH CO LTD (KR)
PAIK SEUNG KWAN (KR)
PAIK SEUNG KWAN (KR)
International Classes:
A61C8/00
Foreign References:
| KR101029068B1 | 2011-04-15 | |||
| KR101650185B1 | 2016-08-22 | |||
| KR20170071015A | 2017-06-23 | |||
| EP1967157A1 | 2008-09-10 | |||
| US20150230889A1 | 2015-08-20 | |||
| KR102148156B1 | 2020-08-27 |
Attorney, Agent or Firm:
KIM, Joon Soo (KR)
Download PDF:
Previous Patent: DIGITAL CURRENCY OPERATION SYSTEM
Next Patent: FUSION PROTEIN COMPRISING CELL-PENETRATING PEPTIDE AND FKBP12 AND USE THEREOF
Next Patent: FUSION PROTEIN COMPRISING CELL-PENETRATING PEPTIDE AND FKBP12 AND USE THEREOF